EventsThe 21st International Electronic Conference on Synthetic Organic Chemistry
Published
This submission belongs to the session D. Polymer and Supramolecular Chemistry of the event The 21st International Electronic Conference on Synthetic Organic Chemistry
Published date
03 Nov, 2017
Citation
Vaibhav V Kulkarni, Sagar Arekar, Lalit V Sonawane, Design and Characterization of Polymeric Floating Microspheres of Levofloxacin Hemihydrate., in Proceedings of The 21st International Electronic Conference on Synthetic Organic Chemistry, 1 November–30 November 2017, MDPI: Basel, Switzerland, doi: 10.3390/ecsoc-21-04811
Share
Email
Facebook
Twitter
LinkedIn

Design and Characterization of Polymeric Floating Microspheres of Levofloxacin Hemihydrate.

Sagar Arekar 1
Lalit V Sonawane 2
1. School of Pharmacy, Swami Ramanand Tirth Marathwada University, Nanded 431306, India
2. Department of Quality Assurance , Maharashatra College of Pharmacy, Nilanga.
Abstract

The complex of Levofloxacin and Chitosan lead to formation of water soluble complex. This complex of Levofloxacin was then formulated into floating beads calcium alginate  with maximum entrapment of Levofloxacin found to be about 75 %( f10) and the entrapment was found to be significantly higher as compared to the other formulations ( f1 to f9). In- Vitro Release studies of the beads f10 was found to significantly improve the release of Levofloxacin as compared to other formulations.. The mean particle size of f10 microspheres and surface morphology were determined by SEM Resulting in Porous and Rough Surface of microspheres.The drug release kinetics were studied as zero order, first order , Higuchi , Koresmeyer-Peppas equations , good  linearity was found in Higuchi’s Equation (R2= 0.9310) indicating the release of the drug from Microspheres is  based on Fickian Diffusion .

Keywords
Levofloxacin
Chitosan
Calcium Alginate
Microsphers
release kinetics
SEM
Fickian Diffusion
Manuscript
Poster
proceedings 21 ECSOC LEVO-1.pdf
Microwave-Assisted Facile Synthesis and anticonvulsant evaluation of Novel N-(3-chloro-2-oxo-4-substituted phenyl azetidin-1-yl)-2-(1, 3-dioxoisoindolin-2-yl) acetamides
Industrial Method for preparing 3-​chloromethyl oxacephem antibiotic nucleus